Registered entities
CASI Pharmaceuticals Inc.
Reg. No. 58-1959440United States
Entremed Inc
Reg. No. 895051United States
Innovation
7 patent families (4 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace accelerating. Cited 106 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Social engagement
Social engagement: 1.5K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 3 | 50% |
Recent activity
19 Nov 2025
Leadership hire
Non-Executive Chairman of the CASI Board of Directors
4 Nov 2025
Event
67th American Society of Hematology Annual Meeting and Exposition
26 Sep 2025
Leadership hire
Independent Director